| Mechanistic considerations for the use of monoclonal antibodies for cancer therapy PM Glassman, JP Balthasar Cancer biology & medicine 11 (1), 20, 2014 | 166 | 2014 |
| Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier OA Marcos-Contreras, CF Greineder, RY Kiseleva, H Parhiz, LR Walsh, ... Proceedings of the National Academy of Sciences 117 (7), 3405-3414, 2020 | 120 | 2020 |
| Pharmacokinetic and pharmacodynamic properties of drug delivery systems PM Glassman, VR Muzykantov Journal of Pharmacology and Experimental Therapeutics 370 (3), 570-580, 2019 | 115 | 2019 |
| Targeting drug delivery in the vascular system: Focus on endothelium PM Glassman, JW Myerson, LT Ferguson, RY Kiseleva, VV Shuvaev, ... Advanced drug delivery reviews 157, 96-117, 2020 | 82 | 2020 |
| Flexible nanoparticles reach sterically obscured endothelial targets inaccessible to rigid nanoparticles JW Myerson, B Braender, O Mcpherson, PM Glassman, RY Kiseleva, ... Advanced Materials 30 (32), 1802373, 2018 | 82 | 2018 |
| Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies PM Glassman, JP Balthasar Journal of pharmacokinetics and pharmacodynamics 43, 427-446, 2016 | 78 | 2016 |
| Vascular drug delivery using carrier red blood cells: focus on RBC surface loading and pharmacokinetics PM Glassman, CH Villa, A Ukidve, Z Zhao, P Smith, S Mitragotri, ... Pharmaceutics 12 (5), 440, 2020 | 75 | 2020 |
| Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation JW Myerson, PN Patel, KM Rubey, ME Zamora, MH Zaleski, N Habibi, ... Nature nanotechnology 17 (1), 86-97, 2022 | 65 | 2022 |
| Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development PM Glassman, JP Balthasar Drug metabolism and pharmacokinetics 34 (1), 3-13, 2019 | 64 | 2019 |
| Targeting therapeutics to endothelium: are we there yet? RY Kiseleva, PM Glassman, CF Greineder, ED Hood, VV Shuvaev, ... Drug delivery and translational research 8, 883-902, 2018 | 63 | 2018 |
| Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers PM Glassman, ED Hood, LT Ferguson, Z Zhao, DL Siegel, S Mitragotri, ... Advanced drug delivery reviews 178, 113992, 2021 | 53 | 2021 |
| Assessments of antibody biodistribution PM Glassman, L Abuqayyas, JP Balthasar The Journal of Clinical Pharmacology 55 (S3), S29-S38, 2015 | 49 | 2015 |
| Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions JS Brenner, K Bhamidipati, PM Glassman, N Ramakrishnan, D Jiang, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (4), 1495-1506, 2017 | 37 | 2017 |
| Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys PM Glassman, Y Chen, JP Balthasar Journal of pharmacokinetics and pharmacodynamics 42, 527-540, 2015 | 29 | 2015 |
| Combating complement's deleterious effects on nanomedicine by conjugating complement regulatory proteins to nanoparticles Z Wang, ED Hood, J Nong, J Ding, OA Marcos‐Contreras, PM Glassman, ... Advanced Materials 34 (8), 2107070, 2022 | 28 | 2022 |
| Molecularly engineered nanobodies for tunable pharmacokinetics and drug delivery PM Glassman, LR Walsh, CH Villa, OA Marcos-Contreras, ED Hood, ... Bioconjugate chemistry 31 (4), 1144-1155, 2020 | 25 | 2020 |
| Targeting vascular inflammation through emerging methods and drug carriers J Nong, PM Glassman, VR Muzykantov Advanced drug delivery reviews 184, 114180, 2022 | 22 | 2022 |
| Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors NJ Mason, N Chester, A Xiong, A Rotolo, Y Wu, S Yoshimoto, P Glassman, ... MAbs 13 (1), 2004638, 2021 | 20 | 2021 |
| The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series) JS Brenner, RY Kiseleva, PM Glassman, H Parhiz, CF Greineder, ... Pulmonary circulation 8 (1), 2045893217752329, 2018 | 16 | 2018 |
| Targeted in vivo loading of red blood cells markedly prolongs nanocarrier circulation PM Glassman, CH Villa, OA Marcos-Contreras, ED Hood, LR Walsh, ... Bioconjugate Chemistry 33 (7), 1286-1294, 2022 | 15 | 2022 |
